Top Clinical Trials companies in Australia by Net Income

This ranking features the top 4 Clinical Trials companies in Australia ranked by Net Income, totalling a Net Income of USD -21.46 M, for January 15, 2025.

Australia

Clinical Trials

#	Name	Net Income	Reported Date	Stock Price	Change	Country
1	Australian Clinical Labs Limited 1 ACL.AX	USD 15.96 M	June 30, 2024	USD 2.14	0.82%	Australia
2	Telix Pharmaceuticals Limited 2 TLX.AX	USD 3.55 M	Dec. 31, 2023	USD 15.47	4.25%	Australia
3	Alterity Therapeutics Limited 3 ATHE	USD -12.75 M	June 30, 2024	USD 3.31	-4.06%	Australia
4	Clarity Pharmaceuticals Ltd 4 CU6.AX	USD -28.22 M	June 30, 2024	USD 2.37	1.84%	Australia

Frequently Asked Questions

Which Clinical Trials company in Australia has the highest Net Income ?

The Clinical Trials company in Australia with the highest Net Income is Australian Clinical Labs Limited (ASX: ACL.AX) at USD 15.96 M.
Which Clinical Trials company in Australia has the lowest Net Income ?

The Clinical Trials company in Australia with the lowest Net Income is Clarity Pharmaceuticals Ltd (ASX: CU6.AX) at USD -28.22 M.

What are the top 10 Clinical Trials companies in Australia by Net Income ?

The top 10 Clinical Trials companies in Australia by Net Income are Australian Clinical Labs Limited, Telix Pharmaceuticals Limited, Alterity Therapeutics Limited and Clarity Pharmaceuticals Ltd.
What are the bottom 10 Clinical Trials companies in Australia by Net Income ?

The bottom 10 Clinical Trials companies in Australia by Net Income are Clarity Pharmaceuticals Ltd, Alterity Therapeutics Limited, Telix Pharmaceuticals Limited and Australian Clinical Labs Limited.